Ibrexafungerp
Back to search| Scientific Name: | Ibrexafungerp |
| Brand Name: | Brexafemme |
| Company Owner: | Not Available |
| Mechanism Of Action | β-1, 3-glucan synthase is composed of a catalytic subunit, FKS1 or FKS2, and a GTP-binding regulatory subunit, Rho1. |
| Description of the Drug: | Ibrexafungerp is a triterpene antifungal indicated in the treatment of vulvovaginal candidiasis and prevention of recurrent vulvovaginal candidiasis in post-menarchal patients. |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB12471
